An Observational Study of Patients With Primary Mitochondrial Disease (SPIMM-300)

NCT03048617 · clinicaltrials.gov ↗
COMPLETED
Status
215
Enrollment
INDUSTRY
Sponsor class

Conditions

Sponsor

Stealth BioTherapeutics Inc.